mayo clinic q&a podcast: expanding the donor pool – hepatitis c no longer a barrier to transplant
Published 2 years ago • 1.4K plays • Length 32:00Download video MP4
Download video MP3
Similar videos
-
12:57
mayo clinic q&a podcast: mayo clinic expands living liver donation program
-
25:05
mayo clinic q&a podcast: reducing rejection by reversing order of heart-liver transplant
-
1:19
hepatitis c-mayo clinic
-
2:54
mayo clinic study reveals new drugs to treat hepatitis c in post liver transplant patients
-
12:18
viral hepatitis (a, b, c, d, e) - causes, symptoms, diagnosis, treatment & pathology
-
21:54
how we cured hepatitis c
-
18:16
my experience with hepatitis c
-
15:51
mayo clinic q&a podcast: cardiac risks of off-label drugs for covid-19
-
1:38
how should i proceed with my current cancer treatment plan? - mayo clinic
-
11:46
hepatitis c overview-mayo clinic
-
11:34
mayo clinic q&a podcast: transplant surgeries and covid-19
-
16:16
mayo clinic q&a podcast: fighting covid-19 with mayo clinic laboratories
-
24:25
mayo clinic q&a podcast: why some patients need a second heart surgery
-
14:40
mayo clinic q&a podcast: how public health measures can help reopen the country
-
11:04
mayo clinic q&a podcast: critical care units prepare for covid-19
-
1:07
mayo clinic minute: what is hepatitis c?
-
1:09
what is hepatitis c? - mayo clinic
-
17:11
mayo clinic q&a podcast: treating and preventing liver cancer
-
2:24
using hepatitis c-infected kidneys in transplantation | expander study faq's
-
1:18
current hepatitis c treatments - mayo clinic
-
11:30
mayo clinic q&a podcast: increased heart disease risk, even a year after covid-19 infection
-
20:40
mayo clinic q&a podcast: when it comes to covid-19, who are 'long-haulers?'